{"transactions":[{"id":788614,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T20:30:12.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest monthly following May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":85000,"derivative":{"exercise_price":33.93,"expiration_date":"2036-05-04","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001193125-26-212116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000119312526212116/ownership.xml","form_type":"4"}},{"id":788613,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-07T20:30:12.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes RSUs."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001193125-26-212116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000119312526212116/ownership.xml","form_type":"4"}},{"id":1072445,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-07T20:38:02.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on August 7, 2026, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":10.75,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-105132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000095017025105132/ownership.xml","form_type":"4"}},{"id":1411017,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-10T20:53:11.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on September 9, 2025, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":260000,"derivative":{"exercise_price":21.51,"expiration_date":"2034-09-08","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0000950170-24-105200","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000095017024105200/ownership.xml","form_type":"4"}},{"id":1629793,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-21T22:00:03.000Z","date":"2024-02-19","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of February 19, 2024 (the \"Vesting Commencement Date\"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":25000,"derivative":{"exercise_price":11.32,"expiration_date":"2034-02-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-24-003673","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000120919124003673/doc4.xml","form_type":"4"}},{"id":2051070,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T22:07:35.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 17, 2023 (the \"Vesting Commencement Date\"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":250000,"derivative":{"exercise_price":0.47,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-004050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000120919123004050/doc4.xml","form_type":"4"}},{"id":2192074,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":49133,"kind":"person","name":"Warner Douglas J","position":1,"cik":"0001941311","reported_name":"Warner Douglas J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-08T22:17:16.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":618160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 25% on August 8, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service\nthrough the applicable vesting date."}],"balance_after":618160,"derivative":{"exercise_price":0.8975,"expiration_date":"2032-08-07","underlying":"Common Stock","underlying_shares":618160},"source":{"system":"sec-edgar","filing":"0001209191-22-044874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1941311/000120919122044874/doc4.xml","form_type":"4"}}]}